Skip to main content
Top

09-05-2024 | Magnetic Resonance Cholangio Pancreatography | Images in clinical gastroenterology

Post cholecystectomy cysto-hepatic duct stricture

Authors: S. Balaraja, Arpit Shastri, Sreedhara B. Chaluvashetty, Arka De

Published in: Indian Journal of Gastroenterology

Login to get access

Excerpt

A 31-year-old lady with a history of cholecystectomy five years back presented with cholestatic jaundice for one-year, increasing over the last two months with fever for one week. Examination revealed icterus and hepatomegaly. Investigations revealed leukocytosis (TLC, 15.4 × 103/µL) and deranged liver function tests (bilirubin, 19.5 mg/dL; aspartate transaminase [AST], 98 IU/L; alanine transaminase [ALT], 50 IU/L; alkaline phosphatase [ALP], 380 IU/L). Magnetic resonance cholangiopancreatography (MRCP) showed dilated right posterior hepatic duct (Fig. 1A). On endoscopic retrograde cholangiopancreatography (ERCP), initial cholangiogram showed prominent common bile duct (CBD) with normal intra-hepatic biliary radicals. Due to discrepancy with MRCP, an occlusion cholangiogram was taken, which revealed a dilated ductal structure arising from the cystic duct area with intervening stricture (Fig. 1B–D). Attempted selective cannulation of this dilated duct was unsuccessful. On endoscopic ultrasound (EUS), aberrant dilated duct arising from cystic duct remnant and draining right posterior hepatic segments was identified. This was punctured with 19G EUS-fine-needle aspiration (FNA) needle and transmural drainage into duodenum was attained with 10F double pigtail technique (DPT) stent (Fig. 2). Fever resolved with marked improvement of liver functions (bilirubin, 3.1 mg/dL) at one-month follow-up. Feasible long-term management options include percutaneous or EUS-guided rendezvous with stricture dilatation, surgery or repeated stent exchanges every three months to keep the choledochoduodenostomy patent.
Literature
1.
go back to reference Cheng YF, Huang TL, Chen CL, Chen YS, Lee TY. Variants of the intrahepatic bile ducts: application in living-related liver transplantation and splitting liver transplantation. Clin Transplant. 1997;11:337–40.PubMed Cheng YF, Huang TL, Chen CL, Chen YS, Lee TY. Variants of the intrahepatic bile ducts: application in living-related liver transplantation and splitting liver transplantation. Clin Transplant. 1997;11:337–40.PubMed
Metadata
Title
Post cholecystectomy cysto-hepatic duct stricture
Authors
S. Balaraja
Arpit Shastri
Sreedhara B. Chaluvashetty
Arka De
Publication date
09-05-2024
Publisher
Springer India
Published in
Indian Journal of Gastroenterology
Print ISSN: 0254-8860
Electronic ISSN: 0975-0711
DOI
https://doi.org/10.1007/s12664-024-01598-y
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Webinar | 06-02-2024 | 20:00 (CET)

Mastering chronic pancreatitis pain: A multidisciplinary approach and practical solutions

Severe pain is the most common symptom of chronic pancreatitis. In this webinar, experts share the latest insights in pain management for chronic pancreatitis patients. Experts from a range of disciplines discuss pertinent cases and provide practical suggestions for use within clinical practice.

Sponsored by: Viatris

Developed by: Springer Healthcare
Live Webinar | 01-10-2024 | 12:30 (CEST)

Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma

Live: Tuesday 1st October 2024, 12:30-14:00 (CEST)

In this live webinar, Professor Martin Dreyling and an esteemed, international panel of CAR-T experts will discuss the very latest data on the safety, efficacy and clinical impact of CAR T-cell therapies in the treatment of r/r DLBCL and r/r FL, as presented at ASH 2023, EU CAR-T 2024, and EHA 2024. 

Please note, this webinar is not intended for healthcare professionals based in the US and UK.

Sponsored by: Novartis Pharma AG

Chaired by: Prof. Martin Dreyling
Developed by: Springer Healthcare